Rating
Buy
Price target
$980
Previous
—
Implied downside
-31%

BNP Paribas Exane analyst Jakob Bluestone upgraded ASML (NASDAQ: ASML) from Neutral to Outperform with a price target of $980.00.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Share

Other ASML notes

Bank of AmericaBuy Reiterate · Jul 27, 2026 maintained CitiBuy Reiterate · Jul 17, 2026 maintained RBC CapitalBuy Maintains · Jul 16, 2026 $2,000from $2,000 JP MorganBuy Reiterate · Jul 16, 2026 from $2,200 Wells FargoBuy Note · Jul 16, 2026 from $2,200

Share on